Lintuzumab Antibody
Lintuzumab (HuM-195) is a humanized monoclonal antibody targeting CD33 on AML cells. It exhibits anti-leukemic activity by inducing cell death via CDC/ADCC and modulating cytokine production. This agent has been investigated in both in vitro assays and clinical trials for acute myeloid leukemia research.
Product Specifications
Product Name Alternative
SGN33, SGN-33, CD33, HuM195, HuM-195, Immunologyrelated, Immunology related, Inflammationrelated, Inflammation related
Target
Immunology/Inflammation related, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.43 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.23 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
